Crescita Therapeutics, Inc.

Crescita Therapeutics, Inc. - PE Ratioverified

CRRTF

Price:

$0.5587

Market Cap:

$14.71M

Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The company owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers and DuraPeel that supports the development of patented formulations to facilitate the delivery of active ingredients into or through the skin. The company's prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermat...[Read more]

Industry

Medical - Pharmaceuticals

IPO Date

2016-04-11

Stock Exchange

OTC

Ticker

CRRTF

The PE Ratio as of August 2026 (TTM) for Crescita Therapeutics, Inc. (CRRTF) is -42.49

According to Crescita Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -42.49. This represents a change of 80.96% compared to the average of -0.05 of the last 4 quarters.

Crescita Therapeutics, Inc. (CRRTF) Historical PE Ratio (quarterly & annually)

How has CRRTF PE Ratio performed in the past?

The mean historical PE Ratio of Crescita Therapeutics, Inc. over the last ten years is 29.80. The current -42.49 PE Ratio has changed -14355.91% with respect to the historical average. Over the past ten years (40 quarters), CRRTF's PE Ratio was at its highest in in the March 2019 quarter at 87.50. The PE Ratio was at its lowest in in the December 2024 quarter at -17.06.

Quarterly (TTM)
Annual

Average

29.80

Median

-0.79

Minimum

-97.96

Maximum

388.89

Crescita Therapeutics, Inc. (CRRTF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Crescita Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.60%

Maximum Annual PE Ratio = 388.89

Minimum Annual Increase = -673.74%

Minimum Annual PE Ratio = -97.96

Quarterly (TTM)
Annual
YearPE RatioChange
2025-97.962.26%
2024-4.14-17.14%
2023-5.00-131.59%
202215.83-229.54%
2021-12.22-103.14%
2020388.893.60%
201910.50183.05%
20183.71-673.74%
2017-0.65-30.22%
2016-0.93-14.64%

Crescita Therapeutics, Inc. (CRRTF) Average PE Ratio

How has CRRTF PE Ratio performed in the past?

The current PE Ratio of Crescita Therapeutics, Inc. (CRRTF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-35.70

5-year avg

-20.70

10-year avg

29.80

Crescita Therapeutics, Inc. (CRRTF) PE Ratio vs. Peers

How is CRRTF’s PE Ratio compared to its peers?

Crescita Therapeutics, Inc.’s PE Ratio is less than Ayurcann Holdings Corp. (-0.45), less than Delivra Health Brands Inc. (-2.93), less than Ayr Wellness Inc. (-0.03), less than Christina Lake Cannabis Corp. (-1.62), less than CV Sciences, Inc. (-3.02), less than Bright Green Corporation (-0.01), less than CanaFarma Hemp Products Corp. (-0.00), less than Healthy Extracts Inc. (-10.78), less than Univec, Inc. (15.50), less than Tristar Wellness Solutions Inc. (-10.00),

Build a custom stock screener for Crescita Therapeutics, Inc. (CRRTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Crescita Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Crescita Therapeutics, Inc. (CRRTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Crescita Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Crescita Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Crescita Therapeutics, Inc. (CRRTF)?

What is the highest PE Ratio for Crescita Therapeutics, Inc. (CRRTF)?

What is the 3-year average PE Ratio for Crescita Therapeutics, Inc. (CRRTF)?

What is the 5-year average PE Ratio for Crescita Therapeutics, Inc. (CRRTF)?

How does the current PE Ratio for Crescita Therapeutics, Inc. (CRRTF) compare to its historical average?